Welcome to our dedicated page for Xcelerate news (Ticker: XCRT), a resource for investors and traders seeking the latest updates and insights on Xcelerate stock.
Xcelerate Inc. reports company developments tied to medical technology, virtual health care and intellectual-property commercialization. Recent updates center on AfiyaSasa Africa LLC, the company’s majority-owned subsidiary focused on an AI-assisted patient portal and healthcare delivery model in Tanzania, including localization work, clinical-site evaluation and medical-technology research and development.
News also covers Xcelerate’s completed sale of its majority interest in the ESN Group, a transaction that moved the company away from the Ceramedx and Earth Natural Beauty skincare businesses. Other recurring themes include patent activity for surgical-tool camera technology, business funding, private-placement financing, auditor-related registration statement updates and broader shareholder communications.
Xcelerate announced that it identified errors in an independent research report by Harbinger Research. CEO Mike O'Shea stated that the report contained inaccuracies about future revenues and potential profitability. The company has contacted Harbinger Research to correct the misleading information, and a retraction is expected soon. Investors and stakeholders are advised to stay informed through Xcelerate's website.
Xcelerate, Inc. announced a change in auditors from BF Borgers CPA to Bush & Associates CPA due to the former's SEC fraud allegations. The company is confident in the new audit firm's capabilities and expects no material changes in financial statements.
Xcelerate, Inc. announced the filing of its 2023 Annual Report, reporting audited financial results for the year. The company achieved its first revenue year in history, marking significant milestones and progress towards growth. Revenues from the majority interest in ESN Group are set to increase in 2024 due to new contracts.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.